ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
CPF/SRS 投资
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
OPUS GENETICS INC
1.30
+0.0291
2.29%
成交量:
8.54萬
成交額:
11.15萬
市值:
7,782.66萬
市盈率:
-0.86
高:
1.32
開:
1.32
低:
1.29
收:
1.27
52周最高:
1.75
52周最低:
0.6500
股本:
5,990.81萬
流通股本:
3,028.13萬
量比:
5.06
換手率:
0.28%
股息:
- -
股息率:
- -
每股收益(TTM):
-1.5143
每股收益(LYR):
-2.1535
淨資產收益率:
-200.57%
總資產收益率:
-55.20%
市淨率:
4.45
市盈率(LYR):
-0.60
資料載入中...
總覽
公司
新聞
公告
Opus Genetics在關鍵性Lynx-3三期試驗中為首位患者給藥,評估0.75%酚妥拉明眼科溶液治療角膜屈光手術患者中間視覺低對比度條件下視覺障礙的療效
美股速递
·
09/04
Opus Genetics Inc 報告截至 3 月 31 日的季度業績 - 收益摘要
路透中文
·
05/16
Opus Genetics在 ARVO 2025上展示為期 12個月的 OPGx-LCA5基因治療數據Opus Genetics Presents 12-Month OPGx-LCA5 Gene Therapy Data at ARVO 2025
动脉网
·
05/07
Opus Genetics Inc 預計每股虧損25美分 - 財報前瞻
路透中文
·
05/06
Jones Trading:維持Opus Genetics評級,由買入調整至買入評級, 目標價由9.00美元調整至8.00美元。
金融界
·
04/01
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/IRD/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IRD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IRD\",,,,,undefined,":{"symbol":"IRD","market":"US","secType":"STK","nameCN":"OPUS GENETICS INC","latestPrice":1.2991,"timestamp":1757339505056,"preClose":1.27,"halted":0,"volume":85431,"delay":0,"floatShares":30281341,"shares":59908055,"eps":-1.514273,"marketStatus":"交易中","change":0.0291,"latestTime":"09-08 09:51:51 EDT","open":1.32,"high":1.32,"low":1.29,"amount":111467.1053358,"amplitude":0.023622,"askPrice":1.3,"askSize":7600,"bidPrice":1.29,"bidSize":700,"shortable":3,"etf":0,"ttmEps":-1.514273,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1757361600000},"marketStatusCode":2,"adr":0,"listingDate":1100235600000,"exchange":"NASDAQ","adjPreClose":1.27,"preHourTrading":{"tag":"盘前","latestPrice":1.28,"preClose":1.27,"latestTime":"09:25 EDT","volume":24996,"amount":31743.1127892,"timestamp":1757337902411},"postHourTrading":{"tag":"盘后","latestPrice":1.27,"preClose":1.27,"latestTime":"19:05 EDT","volume":267,"amount":339.38,"timestamp":1757113527444},"volumeRatio":5.063653,"impliedVol":0.9026,"impliedVolPercentile":0.6682},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IRD\",,,,,undefined,":{"symbol":"IRD","floatShares":30281341,"roa":"-55.20%","roe":"-200.57%","lyrEps":-2.153504,"volumeRatio":5.063653,"shares":59908055,"dividePrice":0,"high":1.32,"amplitude":0.023622,"preClose":1.27,"low":1.29,"week52Low":0.65,"pbRate":"4.45","psRate":"5.05","week52High":1.75,"institutionHeld":0,"latestPrice":1.2991,"committee":-0.831325,"eps":-1.514273,"divideRate":0,"volume":85431,"delay":0,"ttmEps":-1.514273,"open":1.32,"prevYearClose":1.19,"prevWeekClose":1.27,"prevMonthClose":1.22,"prevQuarterClose":0.9421,"fiveDayClose":1.22,"twentyDayClose":1.07,"sixtyDayClose":0.9909},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IRD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-13","symbol":"IRD","fiscalQuarterEnding":"2025/06","expectedEps":-0.25,"name":null,"time":"盤後","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.12},{"market":"US","date":"2025-05-15","symbol":"IRD","fiscalQuarterEnding":"2025/03","expectedEps":-0.34,"name":null,"time":"盤前","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2025-03-31","symbol":"IRD","fiscalQuarterEnding":"2024/12","expectedEps":-0.34,"name":null,"time":"盤前","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"pre","actualEps":-1.27},{"market":"US","date":"2024-11-12","symbol":"IRD","fiscalQuarterEnding":"2024/09","expectedEps":-0.3,"name":null,"time":"盤前","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.29},{"market":"US","date":"2024-08-13","symbol":"IRD","fiscalQuarterEnding":"2024/06","expectedEps":-0.29,"name":null,"time":"盤前","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":-0.3}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IRD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IRD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1750219200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IRD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IRD","date":"2025-09-05","current":-1.384803,"percent":0.146226,"low":-2.964142,"twenty":-1.335088,"median":-1.160946,"eighty":-0.797415,"high":-0.560128,"avg":-1.196044,"sd":0.429084,"marketCap":80699383},"quantilePoints":[{"date":"2024-10-31","current":-2.785848,"twenty":-2.857166,"median":-2.64666,"eighty":-2.37374,"marketCap":39294383},{"date":"2024-11-08","current":-2.429259,"twenty":-2.692243,"median":-2.607554,"eighty":-2.476187,"marketCap":34264702},{"date":"2024-11-15","current":-1.225421,"twenty":-2.616468,"median":-2.568551,"eighty":-2.326813,"marketCap":33321637},{"date":"2024-11-22","current":-1.142487,"twenty":-2.607554,"median":-2.49612,"eighty":-1.192247,"marketCap":31066518},{"date":"2024-11-29","current":-1.288651,"twenty":-2.607554,"median":-2.173143,"eighty":-1.193702,"marketCap":35040987},{"date":"2024-12-06","current":-1.323479,"twenty":-2.603096,"median":-1.364112,"eighty":-1.225421,"marketCap":35988040},{"date":"2024-12-13","current":-1.288651,"twenty":-2.574123,"median":-1.335088,"eighty":-1.234669,"marketCap":35040987},{"date":"2024-12-20","current":-1.14597,"twenty":-2.527405,"median":-1.303163,"eighty":-1.16559,"marketCap":31161223},{"date":"2024-12-27","current":-1.253822,"twenty":-2.505202,"median":-1.288651,"eighty":-1.163268,"marketCap":34093933},{"date":"2025-01-03","current":-1.462793,"twenty":-2.49612,"median":-1.294455,"eighty":-1.172556,"marketCap":39776255},{"date":"2025-01-10","current":-1.683372,"twenty":-2.442631,"median":-1.320577,"eighty":-1.181843,"marketCap":45774262},{"date":"2025-01-17","current":-1.346698,"twenty":-2.224366,"median":-1.346698,"eighty":-1.20274,"marketCap":36619410},{"date":"2025-01-24","current":-1.335088,"twenty":-1.87928,"median":-1.335088,"eighty":-1.207384,"marketCap":36303725},{"date":"2025-01-31","current":-1.288651,"twenty":-1.676407,"median":-1.329284,"eighty":-1.218206,"marketCap":35040987},{"date":"2025-02-07","current":-1.416355,"twenty":-1.657832,"median":-1.323479,"eighty":-1.225421,"marketCap":38513517},{"date":"2025-02-14","current":-1.335088,"twenty":-1.648544,"median":-1.323479,"eighty":-1.239294,"marketCap":36303725},{"date":"2025-02-21","current":-1.288651,"twenty":-1.616038,"median":-1.323479,"eighty":-1.250654,"marketCap":35040987},{"date":"2025-02-28","current":-1.207384,"twenty":-1.525484,"median":-1.317674,"eighty":-1.232138,"marketCap":32831195},{"date":"2025-03-07","current":-1.160946,"twenty":-1.444218,"median":-1.31187,"eighty":-1.207384,"marketCap":31568457},{"date":"2025-03-14","current":-1.07968,"twenty":-1.411711,"median":-1.30026,"eighty":-1.1772,"marketCap":29358665},{"date":"2025-03-21","current":-1.335088,"twenty":-1.404745,"median":-1.30026,"eighty":-1.16559,"marketCap":36303725},{"date":"2025-03-28","current":-1.637559,"twenty":-1.525484,"median":-1.31187,"eighty":-1.1772,"marketCap":44528506},{"date":"2025-04-04","current":-0.76585,"twenty":-1.525484,"median":-1.306065,"eighty":-1.160946,"marketCap":44060874},{"date":"2025-04-11","current":-0.564318,"twenty":-1.462793,"median":-1.288651,"eighty":-1.14388,"marketCap":32466352},{"date":"2025-04-17","current":-0.581158,"twenty":-1.453505,"median":-1.288651,"eighty":-1.129154,"marketCap":33435158},{"date":"2025-04-25","current":-0.632466,"twenty":-1.414033,"median":-1.288651,"eighty":-1.081468,"marketCap":36387058},{"date":"2025-05-02","current":-0.741567,"twenty":-1.404745,"median":-1.288651,"eighty":-1.054291,"marketCap":42663825},{"date":"2025-05-09","current":-0.787263,"twenty":-1.404745,"median":-1.277041,"eighty":-0.791089,"marketCap":45292790},{"date":"2025-05-16","current":-0.737114,"twenty":-1.402423,"median":-1.253822,"eighty":-0.755291,"marketCap":43209631},{"date":"2025-05-23","current":-0.783669,"twenty":-1.393136,"median":-1.253822,"eighty":-0.759832,"marketCap":45938661},{"date":"2025-05-30","current":-0.771642,"twenty":-1.393136,"median":-1.251182,"eighty":-0.76585,"marketCap":45233661},{"date":"2025-06-06","current":-1.017762,"twenty":-1.393136,"median":-1.225421,"eighty":-0.767335,"marketCap":59661197},{"date":"2025-06-13","current":-1.009213,"twenty":-1.381526,"median":-1.207384,"eighty":-0.771254,"marketCap":59160042},{"date":"2025-06-20","current":-0.947842,"twenty":-1.372239,"median":-1.207384,"eighty":-0.771564,"marketCap":55562472},{"date":"2025-06-27","current":-1.038117,"twenty":-1.360629,"median":-1.184165,"eighty":-0.771642,"marketCap":60854420},{"date":"2025-07-03","current":-1.017762,"twenty":-1.358307,"median":-1.160946,"eighty":-0.77653,"marketCap":59661197},{"date":"2025-07-11","current":-1.139893,"twenty":-1.351342,"median":-1.160017,"eighty":-0.782117,"marketCap":66820540},{"date":"2025-07-18","current":-1.185692,"twenty":-1.346698,"median":-1.152239,"eighty":-0.783669,"marketCap":69505294},{"date":"2025-07-25","current":-1.231492,"twenty":-1.339732,"median":-1.160017,"eighty":-0.783669,"marketCap":72190048},{"date":"2025-08-01","current":-1.129716,"twenty":-1.335088,"median":-1.160248,"eighty":-0.785825,"marketCap":66223928},{"date":"2025-08-08","current":-1.10936,"twenty":-1.335088,"median":-1.151155,"eighty":-0.789762,"marketCap":65030704},{"date":"2025-08-15","current":-1.213067,"twenty":-1.335088,"median":-1.150071,"eighty":-0.791428,"marketCap":70691504},{"date":"2025-08-22","current":-1.177087,"twenty":-1.335088,"median":-1.151155,"eighty":-0.791428,"marketCap":68594722},{"date":"2025-08-29","current":-1.287434,"twenty":-1.335088,"median":-1.160248,"eighty":-0.791428,"marketCap":75025207},{"date":"2025-09-05","current":-1.384803,"twenty":-1.335088,"median":-1.160946,"eighty":-0.797415,"marketCap":80699383}],"updateTime":1757331898608},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IRD\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1194408460","title":"Opus Genetics在關鍵性Lynx-3三期試驗中為首位患者給藥,評估0.75%酚妥拉明眼科溶液治療角膜屈光手術患者中間視覺低對比度條件下視覺障礙的療效","url":"https://stock-news.laohu8.com/highlight/detail?id=1194408460","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194408460?lang=zh_tw&edition=fundamental","pubTime":"2025-09-04 20:05","pubTimestamp":1756987523,"startTime":"0","endTime":"0","summary":"Opus Genetics公司宣布,在其关键性Lynx-3三期临床试验中成功为第一位患者给药。该试验旨在评估0.75%酚妥拉明眼科溶液在治疗角膜屈光手术患者中间视觉、低对比度条件下视觉障碍方面的有效性和安全性。\n这项重要的三期临床试验标志着该公司在眼科治疗领域取得的重要进展,为那些在中间光照和低对比度环境下出现视觉困扰的角膜屈光手术患者提供了新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRD","BK4139","BK4007"],"gpt_icon":0},{"id":"2535548783","title":"Opus Genetics Inc 報告截至 3 月 31 日的季度業績 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2535548783","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535548783?lang=zh_tw&edition=fundamental","pubTime":"2025-05-16 16:12","pubTimestamp":1747383174,"startTime":"0","endTime":"0","summary":"Opus Genetics Inc 报告截至 3 月 31 日的季度业绩 - 收益摘要Opus Genetics Inc IRD.OQ报告,截至3月31日的季度调整后每股亏损24美分,高于去年同期的每股-29美分。Opus Genetics 公司公布的本季度每股收益为亏损 24 美分。该公司当季亏损 819 万美元。Opus Genetics Inc 本季度股价下跌了 3.2%,今年迄今为止下跌了 20.2%。华尔街对 Opus Genetics Inc 的 12 个月目标价中位数为 8.00 美元。本摘要由 LSEG 数据于世界协调时 5 月 16 日上午 08:12 自动生成。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nL4T3RO0L5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRD","BK4007","BK4139"],"gpt_icon":0},{"id":"2533938455","title":"Opus Genetics在 ARVO 2025上展示為期 12個月的 OPGx-LCA5基因治療數據Opus Genetics Presents 12-Month OPGx-LCA5 Gene Therapy Data at ARVO 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2533938455","media":"动脉网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533938455?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 20:31","pubTimestamp":1746621060,"startTime":"0","endTime":"0","summary":"Opus Genetics Presents 12-Month OPGx-LCA5 Gene Therapy Data at ARVO 2025OPGx-LCA5基因疗法在2025年ARVO会议上展示12个月数据May 07, 20252025年5月7日","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050720343094ef41c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050720343094ef41c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IRD","BK4139","BK4007"],"gpt_icon":0},{"id":"2533531633","title":"Opus Genetics Inc 預計每股虧損25美分 - 財報前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2533531633","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533531633?lang=zh_tw&edition=fundamental","pubTime":"2025-05-06 20:33","pubTimestamp":1746534788,"startTime":"0","endTime":"0","summary":"Opus Genetics Inc 预计每股亏损25美分 - 财报前瞻) Opus Genetics Inc IRD.OQ IRD.O预计在5月8日公布截至2025年3月31日的业绩(,季度收入将有所增长。LSEG 分析师对 Opus Genetics 公司的平均预期是每股亏损 25 美分。华尔街对 Opus Genetics 公司 12 个月目标价的中位数为 8.00 美元,高于上一次 0.95 美元的收盘价。5月6日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。如有任何其他问题或反馈,请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nL4T3RE117:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRD"],"gpt_icon":0},{"id":"2524116551","title":"Jones Trading:維持Opus Genetics評級,由買入調整至買入評級, 目標價由9.00美元調整至8.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2524116551","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524116551?lang=zh_tw&edition=fundamental","pubTime":"2025-04-01 20:33","pubTimestamp":1743510816,"startTime":"0","endTime":"0","summary":"Jones Trading:维持Opus Genetics(IRD.US)评级,由买入调整至买入评级, 目标价由9.00美元调整至8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040120374094c8ab7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040120374094c8ab7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IRD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}]}}